ThermoGenesis reveals intellectual property acquisition by ImmuneCyte
By Akshay Kedari  Date: 2020-04-14

ThermoGenesis reveals intellectual property acquisition by ImmuneCyte

ThermoGenesis Holdings, Inc. has recently announced the acquisition of intellectual property by ImmuneCyte Life Sciences, its joint venture. The acquisition has been made by ThermoGenesis, a market leader and pioneer in the development & commercialization of automated cell processing technologies, to develop full human antibody therapeutics for COVID-19 disease.

The intellectual property that has been procured includes 4 monoclonal antibody drug candidates with high affinity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as tools for quantifying and screening efficacy of the neutralizing antibodies. These high-affinity antibodies have been obtained by screening the enriched libraries of B cell from people who have recovered from the COVID-19 disease recently. These technologies were developed by a team of researchers who work under East China Normal University, which is a prestigious university in China. The deal also includes an upfront cash payment for an undisclosed sum as well as low double-digit revenue sharing for the drug candidates.

The recent acquisition is another step towards the development of drug candidates or vaccine for emergency treatment of the patients infected by coronavirus. The convalescent plasma therapy has been applied for this treatment by giving current patients an infusion of plasma from individuals recovered from the disease. ThermoGenesis is developing this therapy by using its IgG/IgM Antibody Fast Detection Kit for SARS-CoV-2. Through the combination of this detection kit with the newly acquired technology by ImmuneCyte, the company will detect individuals who have acquired protective immunity against the coronavirus. Its proprietary cell processing platform will then allow the simultaneous isolation of immune cells and convalescent plasma for the effective development of potential anti-COVID-19 antibody.

The entrance of coronavirus into the cells can be blocked effectively by neutralizing antibodies, which are key effectors in the convalescent plasma, thus achieving anti-viral effects. The recent acquisition can lead to the further development of purified anti-COVID-19 monoclonal and polyclonal neutralizing antibodies as these can be more potent and safer with higher efficacy as compared to convalescent plasma.

Source credit:

https://thermogenesis.com/thermogenesis-announces-its-immunecyte-joint-venture-acquires-key-technologies-to-develop-fully-human-polyclonal-and-monoclonal-antibody-therapeutics-for-covid-19/

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Moovaz acquires The Finder from Singapore Press Holdings (SPH)
Moovaz acquires The Finder from Singapore Press Holdings (SPH)
By Akshay Kedari

Singapore-based relocation services startup, Moovaz has successfully acquired the country’s longest-running publication for expats, The Finder, from Singapore Press Holdings (SPH). According to the agreement, SPH, which prints The Business Time...

Sirius Computer buys Advanced Systems Group to expand western presence
Sirius Computer buys Advanced Systems Group to expand western presence
By Akshay Kedari

Sirius Computer Solutions, Inc. which is a prominent national IT solutions integrator, has recently announced it has bought Advanced Systems Group, based in Denver. The purchase had been closed on May 31 and will help Sirius majorly expand its footpr...

SK Telecom launches TEAC applications to support 5G startups
SK Telecom launches TEAC applications to support 5G startups
By Akshay Kedari

SK Telecom, a South Korean telecommunications firm, has recently launched TEAC (TIP Ecosystem Acceleration Center) program applications to produce new and advanced growth drivers with the help of next-gen 5G edge services to aid businesses as they co...

SpaceX halts 1st astronaut launch due to stormy weather in Florida
SpaceX halts 1st astronaut launch due to stormy weather in Florida
By Akshay Kedari

SpaceX, an American aerospace and space transportation services provider, has reportedly halted its 1st U.S. astronaut launch into orbit from Florida in 9 years. This landmark moment for the company and NASA has recently been hindered by the stormy w...

UV Angel ties up with Smile One Services, launches new dental products
UV Angel ties up with Smile One Services, launches new dental products
By Akshay Kedari

UV Angel, a company renowned in the field of pathogen control technology, has recently announced that it has partnered with Smile One Services, which is dental service organization (DSO)  based in Michigan. Reportedly, the partnership has been i...